What is XG Sciences?
Founded in 2006 and headquartered in Lansing, Michigan, XG Sciences specializes in the production of graphene nanoplatelets. The company's product portfolio includes materials for concrete, silicon-graphene lithium-ion battery anodes, 3D printing, and other bulk material applications, aiming to enhance properties such as flexural modulus. The enterprise-level funding context suggests XG Sciences is in a growth phase, likely scaling its manufacturing capabilities and expanding market reach for its innovative graphene-based solutions.
How much funding has XG Sciences raised?
XG Sciences has raised a total of $886K across 2 funding rounds:
Debt
$350K
Debt
$536K
Debt (2020): $350K with participation from PPP
Debt (2021): $536K led by PPP
Key Investors in XG Sciences
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for XG Sciences?
The substantial enterprise-level funding positions XG Sciences for accelerated growth and technological advancement. Future strategic initiatives are expected to focus on expanding production capacity, further research and development into novel graphene applications, and solidifying its market presence in sectors like energy storage and advanced manufacturing. This strategic investment signals confidence in the company's trajectory and its potential to disrupt traditional material science markets.
See full XG Sciences company page
